Article

Optimising MRI in Multiple Sclerosis Drug Development

Optimal designs for proof-of-concept studies in multiple sclerosis

Read more

This review will summarize important design issues in proof-of-concept studies of RRMS with an emphasis on optimizing neuroimaging outcome measures designed to help speed clinical development of novel drugs and biologics.

Authors:

Chief Development Officer
Vice President, Scientific Solutions, Neuroscience

Want to learn more about Worldwide Clinical Trials?